✨
AI Summary
- SGLT2 inhibitors like empagliflozin reduce urinary uromodulin without tubular injury.
- EMPA-KIDNEY trial data suggest novel mechanisms for kidney protection.
- Uromodulin reduction offers clues to SGLT2 inhibitor action.
Guests on This Episode
GM
Greco Malijan
1 podcast appearance